Coating of silver nanoparticles (AgNPs) on glass fibers by a chemical method as plasmonic surface-enhanced Raman spectroscopy (SERS) sensors to detect molecular vibrations of Doxorubicin (DOX) drug in blood plasma

In the present study, Doxorubicin (DOX) drug in healthy blood plasma was the focus of the investigation by surface-enhanced Raman scattering (SERS). In recent years, chemotherapy has been the most popular treatment for various types of cancer; however, its adverse side effects on the patient's health have made a negative aspect regarding the use of this technique. DOX is the most common chemotherapy drug and is used for the treatment of an extensive range of human malignancies. The surface-enhanced Raman scattering (SERS) is a precise technique for the detection of chemicals and biomaterials with significantly low concentrations. The glass fiber substrates coated with silver nanoparticles (AgNPs) have been used to detect DOX. First, the Tollens' method was applied to prepare the AgNPs, and the characteristics of fabricated AgNPs were evaluated using ultraviolet–visible spectroscopy (UV–Vis) and X-ray diffraction (XRD). Then, AgNPs were coated on the glass fiber substrate by a chemical method. Finally, the enhancement of the Raman signal resulted from the molecular vibrations of DOX was evaluated using these SERS-active substrates as plasmonic and Raman spectroscopy sensors. Afterward, for making the sensors practical, the DOX in blood plasma were deposited on the fabricated sensors, and the Raman vibrations were evaluated. The SERS-active substrates, AgNPs deposited on glass fiber substrates, were fabricated for the detection of DOX in and out of the blood plasma; the limit of detection (LOD) for both was 10^?10 M, and the mean relative standard deviation at concentrations of 10^?10 M of DOX out of blood plasma, and 10^?10 M of DOX in blood plasma were obtained to be 3.76% and 3.61%, respectively for ten repeated measurements in which the AgNPs were SERS-active substrates of the biosensors for detecting the DOX. In addition, the enhancement factor was calculated both experimentally and via finite-difference time-domain (FDTD) simulation, which was 29.76 × 10³ and 24.95 × 10³, respectively. Therefore, these SERS-active substrates can be used to develop microsensors and show positive results for SERS-based investigations.